Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FADS1 | O60427 | 1/20 | 0.39 |
| ▸ | DRD2 | P14416 | 5/20 | 0.39 |
| ▸ | DRD3 | P35462 | 4/20 | 0.39 |
| ▸ | NSD2 | O96028 | 1/20 | 0.38 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.38 |
| ▸ | MGLL | Q99685 | 2/20 | 0.37 |
| ▸ | TNF | P01375 | 1/20 | 0.37 |
| ▸ | LITAF | Q99732 | 1/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | PRKDC | P78527 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17169542 | 0.81 | HTR2A (0.37) | DRD3MGLLPRKDC | |
| SCHEMBL17169533 | 0.81 | HTR7 (0.39) | MGLLPRKDC | |
| SCHEMBL17169530 | 0.81 | HTR2A (0.36) | DRD3MGLLPRKDC | |
| SCHEMBL17169544 | 0.81 | HTR7 (0.39) | MGLLPRKDC | |
| SCHEMBL17173248 | 0.75 | FADS1 (0.41) | FADS1DRD2DRD3NSD2NOTUM | |
| SCHEMBL17169538 | 0.74 | FADS1 (0.40) | FADS1DRD2DRD3NSD2NOTUM | |
| SCHEMBL16790773 | 0.72 | DRD2 (0.49) | FADS1DRD2DRD3NSD2NOTUM | |
| SCHEMBL17173249 | 0.72 | DRD2 (0.40) | DRD2DRD3NSD2NOTUMMGLL | |
| SCHEMBL19749032 | 0.71 | OPRL1 (0.45) | — | |
| SCHEMBL26828145 | 0.71 | SLC18A3 (0.39) | ALOX5KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160276603-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2016-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160276603-A1 | Organic Electroluminescent Materials and Devices | EML4, BICRA, TBCB | FADS1 3699/4885DRD2 3257/4885DRD3 3329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.